COMP <GO>
ALGN vs JNJ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Align Technology Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: ALGN 3
— JNJ 11
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: ALGN
LAST: $149.89 (-2.49%) • MKT CAP: $10.92B
options-implied-move
6.60%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
options-implied-move
7.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALGN VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALGN | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.20% | 67.90% | -0.70 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.10% | 25.50% | -14.40 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 18.5x | -1.50 | ALGN | /valuation <GO> |
| Free Cash Flow Yield | 4.49% | 2.97% | +1.52 | ALGN | /fcf-yield <GO> |
| Operating Margin | 13.50% | 34.70% | -21.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 10.20% | 28.50% | -18.30 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | 6.00% | -5.10 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.62 | 5.59 | -0.97 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.60% | 7.20% | -0.60 | ALGN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.8 | 60.4 | -10.54 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 1.08 | -0.18 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.7x | 23.0x | +1.70 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.92B | $662.49B | -$651.57B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALGN REV | JNJ REV | ALGN GROSS % | JNJ GROSS % | ALGN FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.03B | $94.19B | 67.2% | 67.9% | $490.8M | $19.70B |
| FY 2024 | $4.00B | $88.82B | 70.0% | 69.1% | $622.7M | $19.84B |
| FY 2023 | $3.86B | $85.16B | 44.0% | 44.0% | $612.0M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALGN // BETA 0.90
JNJ // BETA 1.08